Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹1,005 Cr₹484 Cr₹766 Cr₹598 Cr

What is the latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA is ₹1,005 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹1,005 Cr
Mar2023₹484 Cr
Mar2022₹766 Cr
Mar2021₹598 Cr

How is Cash Flow from Operating Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹1,005 Cr
107.60
Mar2023 ₹484 Cr
-36.86
Mar2022 ₹766 Cr
28.25
Mar2021 ₹598 Cr -

Compare Cash Flow from Operating Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹27,434.7 Cr 0.4% 0.2% 39.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,076.0 Cr 0.3% -4.9% 15.8% Stock Analytics
DIVIS LABORATORIES ₹173,924.0 Cr 0.2% 10% 53.5% Stock Analytics
CIPLA ₹121,456.0 Cr 2.3% 1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,197.0 Cr 5.7% 15% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,761.0 Cr 0.8% -0.9% 17.4% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.4%

0.2%

39.4%

SENSEX

0.9%

1.8%

11.1%


You may also like the below Video Courses